Skip to content

Clinical trials

Phase 2 Granulomatosis with Polyangiitis trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Granulomatosis with Polyangiitis Phase: Phase 2 Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20021
20032
20071
20131
20142
20181
20193
20231
20241
20253

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Terminated3
Active, not recruiting2
Recruiting2
Unknown status2
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute of Allergy and Infectious Diseases (NIAID)5
Assistance Publique - Hôpitaux de Paris2
InflaRx GmbH2
Novartis Pharmaceuticals2
Anthera Pharmaceuticals1
Hoffmann-La Roche1
Imperial College London1
Mayo Clinic1
NYU Langone Health1
Nippon Kayaku Co., Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Granulomatosis with Polyangiitis21
Microscopic Polyangiitis10
Vasculitis9
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis6
Churg-Strauss Syndrome3
Arthritis, Rheumatoid2
Giant Cell Arteritis2
Inflammation2
Lupus Erythematosus, Systemic2
Polyarteritis Nodosa2

Trials

Showing 26 to 21 of 21. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.